Synthetic lethality in MTAP-deleted tumors: a promising avenue through targeted disruption of the protein methylation pathway.
| Autor: | Boscolo Bielo L; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy., Curigliano G; Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Dec; Vol. 35 (12), pp. 1080-1082. |
| DOI: | 10.1016/j.annonc.2024.09.009 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|